Vorsitz/Chair: Victor Mauri (Köln), Mohammad Sherif (Berlin)
Agenda
08:00
(V683)
Characteristics and outcomes of patients with eccentric aortic valve calcification undergoing transcatheter aortic valve implantation
A. Pohlmeyer (Kiel)
Zum Abstract
08:07
Diskussion
08:11
(V684)
Coronary CTA and CT-FFR reliably detect relevant coronary artery disease pre TAVI in patients without PCI
D. Felbel (Ulm)
Zum Abstract
08:18
Diskussion
08:22
(V685)
AI-driven Biomarker Implementation of Myocardial Injury and Fibrosis Enhances Risk Prediction in Patients Undergoing TAVR
F. Böckling (Frankfurt am Main)
Zum Abstract
08:29
Diskussion
08:33
(V686)
Progression and Outcomes of Mild to Moderate Aortic Stenosis: Insights from the GUARD Prospective Observational Study
B. Al-Kassou (Bonn)
Zum Abstract
08:40
Diskussion
08:44
(V687)
Left Ventricular Global Longitudinal Strain after TAVR with the JenaValve Trilogy system in patients with aortic regurgitation
S. Waezsada (Bad Oeynhausen)
Zum Abstract
08:51
Diskussion
08:55
(V688)
Role of routine esophagoduodenogastroscopy (EGD) to detect clinically silent TEE related esophago-gastric- (GE) lesions following transcatheter tricuspid edge-to-edge-valve repair (TEER)
V. Arsenova (Cottbus)
Zum Abstract
09:02
Diskussion
09:06
(V689)
Predictors of mortality in patients undergoing tricuspid valve surgery
H. Omran (Bad Oeynhausen)
Zum Abstract
09:13
Diskussion
09:17
(V690)
Gender differences among patients undergoing transcatheter tricuspid valve repair using the Edge- To- Edge- Technique; a retrospective observational study